Tim Somervaille

Professor Tim Somervaille serves as a Senior Group Leader at the Cancer Research UK Manchester Institute, which is part of the University of Manchester's Faculty of Biology, Medicine and Health. His research focuses on myeloid malignancies, particularly acute myeloid leukemia (AML), with significant contributions to understanding stem cell biology, transcriptional regulation, and enhancer regions in leukemia pathogenesis.

His research interests span several critical areas in hematology and oncology, with particular emphasis on acute myeloid leukemia, stem cell biology, and transcriptional regulation in cancer. His work explores how dysregulation of transcription factors like RUNX1, GFI1, and LSD1 contributes to leukemia development, with specific focus on enhancer regions and epigenetic mechanisms that block cellular differentiation. His fingerprint analysis shows strong expertise in myeloid biology (100%), acute myeloid leukemia (68%), stem cell research (42%), enhancer regions (27%), LSD1 function (24%), and hematopoietic stem cell biology (22%).

Analysis of his recent publications reveals a strong focus on myeloid malignancies, particularly chronic myelomonocytic leukemia and myelofibrosis. His work combines multi-omics approaches to understand disease heterogeneity, metabolic reprogramming, and immune dysregulation in these conditions. He has contributed significantly to clinical guidelines through the British Society for Haematology, demonstrating the translational impact of his research from basic science to clinical practice.

Professor Somervaille has supervised 15 research projects and has been actively involved in collaborative research, including the NIHR Biomedical Research Centre: Cancer Precision Medicine Theme project (2017-2019). His work contributes to UN Sustainable Development Goals related to good health and well-being, particularly through cancer research and precision medicine approaches.

He maintains an active research program with 77 publications to date, including high-impact articles in journals like Cell Reports Medicine and Leukemia. His datasets on transcriptional regulation in AML have garnered significant attention across social media and news outlets, demonstrating the broader impact of his work beyond traditional academic circles.